UMIN000048298
Prospective Observational Study of Systemic Therapy for HCC in Japan: Exploratory Biomarker-Analysis
Multicenter Observational Study to Evaluate Factors Related to Angiogenesis and Tumor Immunity in Unresectable Hepatocellular Carcinoma
Investigator Initiated Study Promotion Center none·University Hospital Medical Information NetworkRecruiting
Study focus
- Disease/Condition
- Hepatocellular carcinoma
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Investigator Initiated Study Promotion Center none
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Jul 15, 2022
- End date
- N/A
ICD-10 classifications
Malignant neoplasm: HepatoblastomaMalignant neoplasm: Liver cell carcinomaMalignant neoplasm: Other specified carcinomas of liverMalignant neoplasm: Liver, unspecifiedMalignant neoplasm: Hepatic flexure
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000048298
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000048298 through Pure Global AI's free database. This phase not specified trial is sponsored by Investigator Initiated Study Promotion Center none and is currently Recruiting. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.